• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SISTEMAS MEDICOS ALARIS, S.A. DE C.V. BD ALARIS SECONDARY SET; INTRAVASCULAR ADMINISTRATION SET

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SISTEMAS MEDICOS ALARIS, S.A. DE C.V. BD ALARIS SECONDARY SET; INTRAVASCULAR ADMINISTRATION SET Back to Search Results
Model Number 72213N
Medical Device Problem Codes Leak/Splash (1354); Material Separation (1562)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 03/21/2023
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
H3.A device evaluation is anticipated but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.D.4 device expiration date: unknown.H.4 device manufacture date: unknown.
 
Event or Problem Description
It was reported that the bd alaris secondary set experienced component separation and leakage.The following information was provided by the initial reporter: "i¿m hoping you can assist with a report i received regarding a secondary set that disconnected.From what i learned the set disconnected near the spike area causing solution to leak.
 
Additional Manufacturer Narrative
Investigation summary: the customer reported the set disconnected at the spike and returned one used sample.The sample had the spike broken off and the spike was not returned.The spike was clearly snapped with excess force of some kind.The root cause for the failure could not be verified.The supplier of the spike was notified, and they found the issue to have likely happened after their process.The bd process also found no definitive cause for the spike break.A device history record review could not be performed on material 72213n because the lot number is unknown.This incident has been added to our database of reported incidents.Our business team regularly reviews the collected data for identification of emerging trends.
 
Event or Problem Description
It was reported that the bd alaris secondary set experienced component separation and leakage.The following information was provided by the initial reporter: "i¿m hoping you can assist with a report i received regarding a secondary set that disconnected.From what i learned the set disconnected near the spike area causing solution to leak.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD ALARIS SECONDARY SET
Common Device Name
INTRAVASCULAR ADMINISTRATION SET
Manufacturer (Section D)
SISTEMAS MEDICOS ALARIS, S.A. DE C.V.
blvd. insurgentes no. 20351
parque industrial el florido
tijuana
Manufacturer (Section G)
SISTEMAS MEDICOS ALARIS, S.A. DE C.V.
blvd. insurgentes no. 20351
parque industrial el florido
tijuana
Manufacturer Contact
phillip emmert
5859 farinon drive
san antonio, TX 78249
8448235433
MDR Report Key16841903
Report Number9616066-2023-00787
Device Sequence Number15330502
Product Code FPA
UDI-Device Identifier07613203010078
UDI-Public(01)07613203010078
Combination Product (Y/N)N
Initial Reporter StateCA
Initial Reporter CountryUS
PMA/510(K) Number
K790582
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Other,User Facility
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 08/10/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Other
Device Model Number72213N
Device Catalogue Number72213N
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer04/18/2023
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 04/06/2023
Supplement Date Received by Manufacturer08/10/2023
Initial Report FDA Received Date05/01/2023
Supplement Report FDA Received Date08/22/2023
Was Device Evaluated by Manufacturer? (Y/N) Yes
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
-
-